Gujarat Ambuja Exports AGM 2026: ₹0.30 Dividend Details

Key announcements at a glance

Gujarat Ambuja Exports Limited (GAEL) has scheduled its 35th Annual General Meeting (AGM) for Saturday, 5 September 2026. The meeting will be held through Video Conferencing (VC) or Other Audio Visual Means (OAVM), with the start time fixed at 11:00 a.m. IST. Alongside the AGM notice, the company has recommended a final dividend for FY 2025-26. The recommended payout is 30% or ₹0.30 per equity share of face value ₹1 each, subject to shareholder approval. GAEL also communicated key process dates around voting eligibility and dividend entitlement. The updates come at a time when the company has reported strong year-on-year growth in Q1 FY27 profitability. Separately, GAEL highlighted the commissioning of a new specialty chemicals facility, indicating a business expansion beyond its core segments.

35th AGM schedule and mode of meeting

GAEL has formally announced that the 35th AGM will be held on Saturday, 5 September 2026. The meeting will commence at 11:00 a.m. IST, as per the company’s communication. The AGM is planned to be conducted exclusively via VC/OAVM. This format is intended to allow members to attend and participate remotely. The company’s notice also outlines the electronic voting process tied to the meeting. For shareholders, the VC/OAVM arrangement and e-voting timeline are central to participation and resolution approvals. The dividend proposal is one of the key items linked to shareholder approval at the AGM.

Final dividend recommendation: rate, record date, and payout timeline

The Board of Directors has recommended a final dividend of 30% for FY 2025-26. In rupee terms, this translates to ₹0.30 per equity share of ₹1 each. GAEL has fixed 28 August 2026 as the record date for the final dividend. The dividend remains contingent on shareholder approval at the 35th AGM. The company has stated that dividend disbursements will begin on or after 10 September 2026. In addition, GAEL has set 29 August 2026 as the cut-off date for determining eligibility of members to vote electronically and attend the AGM. These dates create two distinct checkpoints, one for dividend entitlement (record date) and another for voting and meeting participation (cut-off date).

Scrutinizer appointment for the voting process

GAEL has appointed CS Niraj Trivedi of M/s. TNT & Associates as the scrutinizer for the AGM voting process. The stated objective is to ensure a fair and transparent voting process. In VC/OAVM AGMs, scrutiny of e-voting and related processes is a key compliance step. The appointment also supports procedural integrity for resolutions that may include financial statements and dividend approval. The company’s disclosure positions the scrutinizer as an independent check within the voting mechanism. This is particularly relevant given that shareholders are not physically present at a venue.

Integrated Annual Report access for shareholders

GAEL announced the dispatch of letters to shareholders whose email addresses are not registered for e-communication. These letters contain a web-link and the exact path to access the Integrated Annual Report for FY 2025-26 and the AGM notice. The intent is to ensure all shareholders can review the company’s financial performance and the resolutions proposed at the AGM. The dispatch is tied to the 35th AGM scheduled on 5 September 2026. By providing the exact navigation path, GAEL is attempting to reduce access friction for shareholders. This step is important when statutory documents are largely distributed electronically. It also supports informed voting on key items including the final dividend.

Q1 FY27 financial performance: revenue, profit, EBITDA, EPS

For the quarter ended June 30, 2026, GAEL reported strong year-on-year growth in both revenue and profitability. Reported consolidated net sales stood at ₹1,594.22 crore in June 2026, up 23.47% from ₹1,291.23 crore in June 2025. Consolidated quarterly net profit was ₹176.77 crore, up 171.87% from ₹65.02 crore. Consolidated EBITDA was reported at ₹271.06 crore, up 114.06% from ₹126.63 crore. On a standalone basis, net sales were ₹1,594.27 crore versus ₹1,291.23 crore, and standalone net profit was ₹176.93 crore versus ₹65.40 crore. Standalone EBITDA stood at ₹271.13 crore compared with ₹126.90 crore in the year-ago quarter. GAEL also reported that EPS increased to ₹3.85 in June 2026 from ₹1.42 in June 2025.

Entry into specialty chemicals: new sodium gluconate facility

A key operational highlight disclosed by the company is the commissioning of India’s first maize starch-based Sodium Gluconate fermentation facility. The unit is located at Hubli, Karnataka, and has a capacity of 30,000 TPA. GAEL described this development as marking its entry into specialty chemicals. The announcement adds context to the company’s broader strategic direction alongside its financial performance. While the disclosure does not provide revenue contribution or ramp-up timelines, the commissioning itself is a tangible capacity addition. For investors tracking product and segment expansion, the facility detail is a specific, measurable milestone.

Registrar and compliance contacts disclosed by the company

GAEL has listed Jupiter Corporate Services Limited as its Registrar & Share Transfer Agent. The address provided is “Ambuja Tower”, Opp. Sindhu Bhavan, Sindhu Bhavan Road, Bodakdev, P.O. Thaltej, Ahmedabad - 380 059, with phone +91-79-61556677, fax +91-79-61556678, email Investor-jcsl@ambujagroup.com, and website www.jcsl.co.in. The Compliance Officer is Mr. Kalpesh Bhupatbhai Dave (Company Secretary & Compliance Officer), Gujarat Ambuja Exports Limited, “Ambuja Tower”, Opp. Sindhu Bhavan, Sindhu Bhavan Road, Bodakdev, P.O. Thaltej, Ahmedabad - 380 054. The CIN disclosed is L15140GJ1991PLC016151, and the contact email is cs@ambujagroup.com, with phone and fax the same as above. The disclosure also mentions an effective period from 05 February 2026 to 04 February 2027.

Stock listing details provided

The company is listed on BSE and NSE, as indicated in the shared details. The BSE stock code is 524226. The NSE symbol is GAEL. These identifiers are typically used by investors and market participants for tracking price, filings, and disclosures on the respective exchanges.

Summary table of key facts and dates

Market impact and why the disclosures matter

The dividend recommendation and record date give shareholders a clear framework for eligibility and timelines, especially with the payout dependent on AGM approval. The cut-off date for voting eligibility is also important for shareholders who want to participate in resolutions through e-voting and attend the VC/OAVM meeting. On the business side, the reported Q1 FY27 numbers highlight a sharp improvement in profitability with revenue growth of about 23.47% year-on-year and net profit growth of roughly 171% on both standalone and consolidated bases. EBITDA growth above 100% year-on-year, as disclosed, suggests improved operating performance during the quarter. The commissioning of the sodium gluconate facility is a discrete operational event that signals diversification into specialty chemicals, supported by a disclosed 30,000 TPA capacity. Together, these disclosures combine corporate governance, shareholder returns, and operating performance in a single reporting cycle.

Conclusion

GAEL’s 35th AGM on 5 September 2026 will be the forum for shareholder consideration of the FY 2025-26 final dividend of ₹0.30 per share. The company has outlined the record date (28 August 2026), voting cut-off date (29 August 2026), and the expected start of dividend disbursement on or after 10 September 2026. In parallel, GAEL has reported strong year-on-year growth in Q1 FY27 revenue and profit, and disclosed the commissioning of a 30,000 TPA sodium gluconate facility at Hubli. The next confirmed milestone for shareholders is the AGM itself, conducted via VC/OAVM at 11:00 a.m. IST.